Position in AMGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$569,252
+$16,144 QoQ
Shares Held
1,572
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,084
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Van Cleef Asset Management,Inc holds $14,679,161 across 8 Drug Manufacturers - General names. AMGN ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,838 | $4,276,346 | |
| 2 | LLY |
ELI LILLY & Co
|
2,762 | $3,312,825 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,933 | $2,432,890 | |
| 4 | ABBV |
AbbVie Inc.
|
7,570 | $1,904,914 | |
| 5 | PFE |
Pfizer Inc
|
44,347 | $1,067,875 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,952 | $625,635 | |
| 7 | AMGN |
Amgen Inc
This page
|
1,572 | $569,252 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,494 | $489,424 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $569,252 | 1,572 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $553,108 | 1,572 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $514,531 | 1,572 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $429,508 | 1,522 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $430,541 | 1,542 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $511,565 | 1,642 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $438,396 | 1,682 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $648,286 | 2,012 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $633,336 | 2,027 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $576,316 | 2,027 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $488,769 | 1,697 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $456,085 | 1,697 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $376,767 | 1,697 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $446,028 | 1,845 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $484,570 | 1,845 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $465,451 | 2,065 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $502,414 | 2,065 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $899,570 | 3,720 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $893,130 | 3,970 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $923,964 | 4,345 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,059,093 | 4,345 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,081,079 | 4,345 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $923,128 | 4,015 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $1,020,452 | 4,015 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $946,977 | 4,015 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $836,869 | 4,128 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||